Acylhydrazones as M1/M3 selective muscarinic agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 21, 1996, Pages 2525-2530

  Wu, Edwin S C ^a   Kover, Alexander ^a   Loch III, James T ^a   Rosenberg, L Paul ^a   Semus, Simon F ^a   Verhoest, Patrick R ^a   Gordon, John C ^a   Machulskis, Anthony C ^a   McCreedy, Sally A ^a   Zongrone, John ^a   Blosser, James C ^a  

^a Astra Arcus USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,8 DIMETHYL 1 OXA 8 AZASPIRO[4.5]DECAN 3 ONE ACETYLHYDRAZONE; CARBACHOL; CYCLIC AMP; HYDRAZONE DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; PIRENZEPINE; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GUINEA PIG; HEART; HIPPOCAMPUS; MOLECULAR DYNAMICS; NONHUMAN; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; TRACHEA;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0342928649     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00471-4     Document Type: Article

References (22)

1. 1. Eckoils, K; Bymaster, F. P.; Mitch, C. H.; Shannon, H. E.; Ward, J. S.; DeLapp, W. Life Sci. 1995, 57, 1183.
2. 2. (a) Hannon, H. E.; Bymaster, F. P.; Calligaro, D. O.; Greenwood, B; Mitch, C. H; Sawyer, B. D.; Ward, J. S.; Wong, D. T; Olesen, P. H.; Sheardown, M. J.; Swedberg, D. B.; Suzdak, P. D.; Sauerberg, P. J. Pharmacol. Exp. Ther. 1994, 269, 271.
3. (b) Street, L.J.; Baker, R.; Book, T.; Kneen, C. O.; MacLeod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders, J.; Herbert, R. H.; Freedman, S. B.; Harley, E. A. J. Med. Chem. 1990, 35, 2690.
4. 3. (a) Wu, E. S. C.; Griffith, R.; Kover, A.; Loch, J. T. III; Mullen, G.; Murray, R. J.; Blosser, J. C.; Machulskis, A. C.; McCreedy S. A. J. Med. Chem. 1995, 38, 1558.
5. (b) Wu, E. S. C.; Mack, R. A.; Kover, A.; Loch, J. T. III; Mullen, G.; Murray, R. J.; Gordon, J.; Machulskis, A. C.; McCreedy S. A.; Blosser, J. C. Bioorg. Med.Chem.Lett., 1995, 5, 1813.
6. (c) Tsukamoto, S.; Fujii, M.; Yasunaga, T.; Matsuda, K.; Wanibuchi, F.; Hidaka, K.; Furuya, T.; Tamura, T. Chem. Pharm. Bull. 1995, 43, 842.
7. 4. Unpublished report.
8. 5. Tecle, H; Lauffer, D. J.; Mirzadegan, T.; Moos, W. H.; Moorland, D. W.; Pavia, M. R.; Scharwz, R. D.; Davis, R. E. Life Sci. 1992, 52, 505. Tecle, H; Lauffer, D. J.; Mirzadegan, T.; Moos, W. H.; Moorland, D. W.; Pavia, M. R.; Scharwz, R. D.; Davis, R. E. Bioorg. Med. Chem. Lett., 1992, 2, 821.
9. 5. Tecle, H; Lauffer, D. J.; Mirzadegan, T.; Moos, W. H.; Moorland, D. W.; Pavia, M. R.; Scharwz, R. D.; Davis, R. E. Life Sci. 1992, 52, 505. Tecle, H; Lauffer, D. J.; Mirzadegan, T.; Moos, W. H.; Moorland, D. W.; Pavia, M. R.; Scharwz, R. D.; Davis, R. E. Bioorg. Med. Chem. Lett., 1992, 2, 821.
10. 6. (a) Tripos Associates, St. Louis, MO.
11. (b) Henderson, R.; Baldwin, J. M.; Ceska, T. A.; Zemlin, F.; Beckmann, E.; Downing, K. H. J. Mol Biol. 1990, 213, 899.
12. (c) Nordvall G.; Hacksell, U.; J. Med. Chem. 1993, 36, 967.
13. 15,16
14. 8. Affinity constants at the muscarinic receptor have been correlated with lipophilicity: Banerjee, S.; Lien, E. Pharm. Res. 1990, 7, 746.
15. 9. The cLog P values for this series were calculated using the MedChem Software by Daylight. The validity of these calculations was verified by the experimental determination of the log P of 2. This compound was partitioned between octanol/buffer at pH 12.08 and the log P was obtained from the assay of both phases. This pH was selected to suppress the ionized form of the compound. The pKa for this series has been determined to fall in the 8 to 9 range. The experimental log P for 2 was found to be -0.24 which is in good agreement with the MedChem value of -0.12 (see Fig. 1).
16. 10. Wess, J. Trends Pharmacol. Sci. 1993, 14, 308.
17. 11. Luthin, G. R.; Wolf, B. B. J. Pharmacol. Exp. Ther. 1984, 226, 648.
18. 12. Gonzales, R. A.; Crews, F. T. J. Neurosci. 1984, 4, 3120.
19. 13. Pontzer, N. J.; Crews, F. T. J. Pharmacol. Exp. Ther. 1990, 253, 921.
20. 14. Ehlert, F. G. J. Pharmacol. Exp. Ther. 1986, 240, 23.
21. 15. Morrison, K. J.; Vanhoutte, P. M. Br. J. Pharmacol. 1992, 106, 672.
22. 16. Leff, P.; Dougal, I. G.; Harper, D. Br. J. Pharmacol. 1993, 110, 239.